Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. [PDF]
Alruwaili M +3 more
europepmc +1 more source
Plasmodium vivax malaria presenting with severe thrombocytopenia [PDF]
Ravinder Pal Singh Makkar +2 more
openalex +1 more source
The reticulocyte restriction: invasion ligand RBP1a of <i>Plasmodium vivax</i> targets human TfR1, prohibitin-2, and basigin. [PDF]
Molina-Franky J +4 more
europepmc +1 more source
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam* [PDF]
Giao T. Phan +7 more
openalex +1 more source
Malária incubada: a mixed methods analysis on knowledge and experiences on Plasmodium vivax and asymptomatic malaria infections in a hard-to-reach and mobile population in the Amazon. [PDF]
Plessis L +10 more
europepmc +1 more source
Age‐Acquired Immunity to aPlasmodium vivaxInvasion Ligand, the Duffy Binding Protein [PDF]
Jennifer L. Cole‐Tobian +7 more
openalex +1 more source
Adjuvants and MHCII modulate the immunogenicity of subdominant epitopes in <i>Plasmodium vivax</i> Duffy binding protein. [PDF]
Vinals DF +8 more
europepmc +1 more source
Performance of OptiMAL® in the diagnosis of Plasmodium vivax and Plasmodium falciparum infections in a malaria referral center in Colombia [PDF]
Beatriz E. Ferro +4 more
openalex +1 more source
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia. [PDF]
Cassidy-Seyoum SA +12 more
europepmc +1 more source

